Mouse Snx9/2700073N08Rik/SDP1 ORF/cDNA clone-Adeno-associate virus(AAV) plasmid (NM_025664.6)

Cat. No.: pGMAAV001588
Size: 10 µg
Concentration: generally 0.5ug/ul, usually not less than 0.3ug/ul
Leading Time: 3-7 working days

Pre-made Mouse Snx9/2700073N08Rik/SDP1 Adeno-associated virus expression plasmid (ITR-vector) for Snx9 AAV packaging, Snx9 AAV production.The purified Mouse Snx9/2700073N08Rik/SDP1 AAV particle serves as an invaluable asset for in-depth in vivo Snx9 studies, mechanism of action (MOA) research, and the evolution of Snx9-associated gene therapy strategies.

Our GM-AAV ITR vector is optimized with the G-NEXT™ multi-serotypes AAV vector system. Explore the G-NEXT™ system in detail.

pdf Datasheet
pdf MSDS
pdf Terms of Use
Purchase
Shipping fee: Limited-time free
For payment issues, contact us.


Product Description

Catalog ID pGMAAV001588
Gene Name Snx9
Accession Number NM_025664.6
Gene ID 66616
Species Mouse
Product Type Adeno-associate virus(AAV) plasmid (overexpression)
Insert Length 1788 bp
Gene Alias 2700073N08Rik,SDP1,SH3PX1
Fluorescent Reporter ZsGreen
Mammalian Cell Selection Null
Fusion Tag 3xflag (C-Terminal)
Promoter TBG
Resistance Amplicin
ORF Nucleotide Sequence ATGGCCACCAAGGCTCGGGTCATGTACGACTTTGCTGCTGAGCCTGGAAACAATGAGCTGACCGTTACTGAAGGAGAAATCATCACAGTTACAAACCCGAATGTTGGTGGAGGATGGCTGGAAGGAAAGAACAACAAAGGAGAGCAGGGGCTTGTTCCTACTGACTACGTGGAAATTTTACCAAACGATGGAAAAGATCCGTTTTCTTGTGGGAATTCAGTAGCCGACCAAGCTTTCCTCGATTCCCTGACAGCTAGCACAGCTCAAACCAACTCATCTTCTGCCAACAGCAATAACCAGGTTGGTGGTGGCAATGACCCCTGGACAGCCTGGAATGCTCCCAAACCTGGGAACTGGGACAGCTCCGATGCCTGGGGCTCCAGGACAGACGGAACTAGCGCTCAGAGGAACAGCAGCGCCAACAACTGGGACACGGGCTTTGGCCACCCACAGGCCTACCAAGGACCAGCAACTGGTGATGATGACGAATGGGATGAAGACTGGGACGACCCCAAGTCCTCCTCACCTTACTTCAAGGATTCAGAACCAGCTGAAGCAGGGGGCATCCAGCGGGGAAACAGTCGTGCGGGTGCCTCCTCCATGAAGCTGCCCCTTAACAAATTTCCTGGATTTGCAAAACCTGGCATGGAGCAGTACTTGTTGGCCAAGCAGCTAGCAAAACCCAAAGAGAAAATCGCCATCATCGTTGGAGATTATGGCCCTATGTGGGTTTATCCTACCTCTACGTTTGACTGTGTGGTAGCTGATCCCCGGAAAGGTTCCAAAATGTACGGTCTGAAGAGCTACATTGAGTATCAGCTAACACCCACTAACACTAACCGATCTGTAAACCACAGATATAAGCACTTTGATTGGTTATATGAGCGTCTCCTGGTTAAGTTTGGGTCTGCCATTCCGATCCCTTCTCTTCCAGACAAGCAGGTCACAGGTCGCTTTGAAGAGGAATTTATCAAAATGCGGATGGAGCGGCTCCAGGCCTGGATGACCAGGATGTGCCGGCACCCGGTGGTGTCAGAAAGTGAAGTTTTCCAGCAGTTCCTGAATTTCCGAGATGAGAAGGAATGGAAGACTGGAAAGAGGAAGGCTGAGAAAGACGAACTGGTGGGAGTGATGATATTTTCCACCATGGAACCAGAGGCTCCTGACTTGGATTTGATAGAAATAGAACAGAAGTGTGACGCTGTGGGGAAGTTCACCAAGGCCATGGATGACGGCGTGAAGGAGCTGCTGACGGTGGGGCAGGAGCACTGGAAGCGCTGCACAGGGCCCTTACCCAAGGAGTATCAGAAGATAGGGAAGGCTCTGCAGAGCTTAGCGGCAGTGTTCAGCTCCAGCGGTTATCAAGGAGAGACCGACCTTAACGATGCAATCACAGAAGCTGGGAAGACGTATGAGGAGATCGCCAGCCTTGTGGCAGAGCAGCCAAAGAAGGACCTCCACTTCCTGATGGAGTGCAACCATGAGTACAAAGGCTTTCTCGGCTGCTTCCCGGACATCATTGGTGCCCACAAGGGAGCAATAGAAAAAGTGAAAGAAAGTGATAAGCTGGTTGCAACTAGTAAAATTACTCCCCAAGACAAGCAGACCATGGTGAAGAGAGTTGGCACCATGTCTTACGCTCTGCAAGCTGAGATGAATCACTTTCACAGTAACCGGATCTATGATTACAACAGTGTCATCCGCCTCTACCTGGAGCAGCAAGTGCAGTTCTATGAAACAATCGCAGAAAAGCTGAGGCAGGCCCTCAGCCGCTTCCCGGTTATGTAA
ORF Protein Sequence MATKARVMYDFAAEPGNNELTVTEGEIITVTNPNVGGGWLEGKNNKGEQGLVPTDYVEILPNDGKDPFSCGNSVADQAFLDSLTASTAQTNSSSANSNNQVGGGNDPWTAWNAPKPGNWDSSDAWGSRTDGTSAQRNSSANNWDTGFGHPQAYQGPATGDDDEWDEDWDDPKSSSPYFKDSEPAEAGGIQRGNSRAGASSMKLPLNKFPGFAKPGMEQYLLAKQLAKPKEKIAIIVGDYGPMWVYPTSTFDCVVADPRKGSKMYGLKSYIEYQLTPTNTNRSVNHRYKHFDWLYERLLVKFGSAIPIPSLPDKQVTGRFEEEFIKMRMERLQAWMTRMCRHPVVSESEVFQQFLNFRDEKEWKTGKRKAEKDELVGVMIFSTMEPEAPDLDLIEIEQKCDAVGKFTKAMDDGVKELLTVGQEHWKRCTGPLPKEYQKIGKALQSLAAVFSSSGYQGETDLNDAITEAGKTYEEIASLVAEQPKKDLHFLMECNHEYKGFLGCFPDIIGAHKGAIEKVKESDKLVATSKITPQDKQTMVKRVGTMSYALQAEMNHFHSNRIYDYNSVIRLYLEQQVQFYETIAEKLRQALSRFPVM

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    Category Cat No. Products Name
    ORF Viral Vector vGMAAV001588 Mouse Snx9 Adeno-associate virus(AAV) particle




    About GMVC

    GDU

    GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.